Barclays’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $164M | Sell |
423,616
-415,284
| -50% | -$154M | 0.03% | 358 |
|
|
2026
Q1 | $246M | Buy |
838,900
+460,014
| +121% | +$151M | 0.06% | 243 |
|
|
2025
Q4 | $133M | Sell |
378,886
-175,435
| -32% | -$59.3M | 0.03% | 389 |
|
|
2025
Q3 | $179M | Sell |
554,321
-39,953
| -7% | -$12.4M | 0.04% | 325 |
|
|
2025
Q2 | $231M | Buy |
594,274
+90,842
| +18% | +$36.5M | 0.05% | 240 |
|
|
2025
Q1 | $219M | Buy |
503,432
+54,352
| +12% | +$21.8M | 0.06% | 229 |
|
|
2024
Q4 | $166M | Sell |
449,080
-172,004
| -28% | -$72M | 0.05% | 266 |
|
|
2024
Q3 | $323M | Sell |
621,084
-368,538
| -37% | -$197M | 0.09% | 170 |
|
|
2024
Q2 | $536M | Sell |
989,622
-35,466
| -3% | -$18.7M | 0.16% | 85 |
|
|
2024
Q1 | $532M | Sell |
1,025,088
-209,835
| -17% | -$104M | 0.18% | 94 |
|
|
2023
Q4 | $582M | Buy |
1,234,923
+142,245
| +13% | +$65.8M | 0.21% | 78 |
|
|
2023
Q3 | $476M | Sell |
1,092,678
-170,723
| -14% | -$77.4M | 0.3% | 62 |
|
|
2023
Q2 | $561M | Buy |
1,263,401
+437,225
| +53% | +$202M | 0.36% | 52 |
|
|
2023
Q1 | $380M | Buy |
826,176
+46,111
| +6% | +$21.9M | 0.17% | 65 |
|
|
2022
Q4 | $400M | Buy |
780,065
+327,413
| +72% | +$166M | 0.18% | 79 |
|
|
2022
Q3 | $206M | Buy |
452,652
+104,400
| +30% | +$50M | 0.22% | 94 |
|
|
2022
Q2 | $168M | Sell |
348,252
-134,530
| -28% | -$66.6M | 0.1% | 154 |
|
|
2022
Q1 | $237M | Sell |
482,782
-169,204
| -26% | -$77.3M | 0.19% | 121 |
|
|
2021
Q4 | $302M | Buy |
651,986
+21,222
| +3% | +$8.93M | 0.11% | 151 |
|
|
2021
Q3 | $235M | Buy |
630,764
+115,734
| +22% | +$44M | 0.11% | 153 |
|
|
2021
Q2 | $197M | Buy |
515,030
+59,614
| +13% | +$22.8M | 0.09% | 178 |
|
|
2021
Q1 | $163M | Buy |
455,416
+81,965
| +22% | +$26.4M | 0.09% | 187 |
|
|
2020
Q4 | $120M | Buy |
373,451
+58,659
| +19% | +$18M | 0.06% | 237 |
|
|
2020
Q3 | $84.5M | Buy |
314,792
+57,016
| +22% | +$15.3M | 0.05% | 266 |
|
|
2020
Q2 | $67.8M | Sell |
257,776
-23,270
| -8% | -$6.21M | 0.05% | 265 |
|
|
2020
Q1 | $63.8M | Sell |
281,046
-191,373
| -41% | -$52.2M | 0.05% | 254 |
|
|
2019
Q4 | $143M | Sell |
472,419
-93,463
| -17% | -$25.7M | 0.08% | 202 |
|
|
2019
Q3 | $136M | Sell |
565,882
-74,406
| -12% | -$20.4M | 0.09% | 191 |
|
|
2019
Q2 | $181M | Buy |
640,288
+136,580
| +27% | +$37.3M | 0.11% | 152 |
|
|
2019
Q1 | $145M | Buy |
503,708
+131,700
| +35% | +$38.1M | 0.1% | 161 |
|
|
2018
Q4 | $97.7M | Sell |
372,008
-47,569
| -11% | -$13.1M | 0.08% | 195 |
|
|
2018
Q3 | $115M | Sell |
419,577
-66,956
| -14% | -$17.4M | 0.08% | 182 |
|
|
2018
Q2 | $116M | Sell |
486,533
-129,719
| -21% | -$30M | 0.1% | 165 |
|
|
2018
Q1 | $135M | Buy |
616,252
+150,039
| +32% | +$35.2M | 0.1% | 164 |
|
|
2017
Q4 | $105M | Buy |
466,213
+121,716
| +35% | +$25.9M | 0.09% | 191 |
|
|
2017
Q3 | $65.4M | Sell |
344,497
-70,697
| -17% | -$13.5M | 0.07% | 230 |
|
|
2017
Q2 | $78.1M | Sell |
415,194
-17,444
| -4% | -$3.13M | 0.08% | 179 |
|
|
2017
Q1 | $71.5M | Buy |
432,638
+165,733
| +62% | +$26.4M | 0.08% | 187 |
|
|
2016
Q4 | $38.4M | Buy |
266,905
+9,829
| +4% | +$1.32M | 0.04% | 341 |
|
|
2016
Q3 | $32.2M | Sell |
257,076
-173,856
| -40% | -$22.4M | 0.04% | 375 |
|
|
2016
Q2 | $56.6M | Buy |
430,932
+144,214
| +50% | +$19.7M | 0.07% | 229 |
|
|
2016
Q1 | $39.6M | Buy |
286,718
+51,358
| +22% | +$6.86M | 0.06% | 269 |
|
|
2015
Q4 | $32.7M | Buy |
235,360
+67,099
| +40% | +$9.24M | 0.04% | 393 |
|
|
2015
Q3 | $23.6M | Sell |
168,261
-147,658
| -47% | -$22.2M | 0.03% | 526 |
|
|
2015
Q2 | $51.8M | Sell |
315,919
-58,532
| -16% | -$9.35M | 0.06% | 285 |
|
|
2015
Q1 | $57.7M | Buy |
374,451
+36,218
| +11% | +$5.16M | 0.07% | 274 |
|
|
2014
Q4 | $42.3M | Sell |
338,233
-134,796
| -28% | -$16.7M | 0.04% | 409 |
|
|
2014
Q3 | $56.3M | Sell |
473,029
-776
| -0.2% | -$89K | 0.05% | 291 |
|
|
2014
Q2 | $50.7M | Sell |
473,805
-105,079
| -18% | -$10.8M | 0.05% | 308 |
|
|
2014
Q1 | $57.3M | Sell |
578,884
-127,531
| -18% | -$11.5M | 0.06% | 259 |
|
|
2013
Q4 | $65M | Buy |
706,415
+65,292
| +10% | +$5.8M | 0.07% | 263 |
|
|
2013
Q3 | $53.2M | Buy |
641,123
+72,763
| +13% | +$6.24M | 0.06% | 275 |
|
|
2013
Q2 | $46.5M | Buy |
+568,360
| New | +$42.5M | 0.06% | 280 |
|
Other funds holding ELV
Barclays's ELV Position: Q2 2026 in Review
Barclays reduced its Elevance Health (ELV) stake by 50% in Q2 2026, selling an estimated $154M and leaving 423,616 shares worth $164M. The position accounts for 0.03% of the portfolio, ranked #358.
Barclays first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $582M in Q4 2023. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Barclays held 423,616 shares of Elevance Health worth $164M as of Q2 2026.
- Barclays sold 415,284 Elevance Health shares in Q2 2026, an estimated $154M.
- Elevance Health made up 0.03% of Barclays's portfolio in Q2 2026, its #358 holding.
- Barclays first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
- Barclays's Elevance Health position peaked at $582M in Q4 2023.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.